The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 73, Issue 3, 2006, Pages 284-291

  Shim, Wan Sub ^a   Kim, Hae Jin ^b   Kang, Eun Seok ^a   Ahn, Chul Woo ^a   Lim, Sung Kil ^a   Lee, Hyun Chul ^a   Cha, Bong Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Inflammation; Metabolic syndrome; Type 2 diabetes mellitus; White blood cell count

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BASOPHIL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; EOSINOPHIL COUNT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LIPID BLOOD LEVEL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MONOCYTE; NEUTROPHIL COUNT; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; ERYTHROCYTE COUNT; FEMALE; HUMANS; INSULIN; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MONOCYTES; NEUTROPHILS; REGRESSION ANALYSIS; TRIGLYCERIDES;

EID: 33746273256     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.02.001     Document Type: Article

References (35)

1. Grundy S.M., Benjamin I.J., Burke G.L., Chait A., Eckel R.H., Howard B.V., et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100 (1999) 1134-1146
2. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339 (1998) 229-234
3. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
4. Ford E.S. The metabolic syndrome and mortality from cardiovascular disease and all causes: finding from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173 (2004) 309-314
5. Alexander C.M., Landsman P.B., Teutsch S.M., and Haffner S.M. Third national health and nutrition examination survey (NHANES III); Nationcal Cholesterol Education Program (NCEP): NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHENES III participants age 50 years and older. Diabetes 52 (2003) 1210-1214
6. Koenig W., Sund M., Frohlich M., Fischer H.G., Lowel H., Doring A., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984-1992. Circulation 99 (1999) 142-237
7. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
8. Yarnell J.W., Baker I.A., Sweetnam P.M., Bainton D., O'Brien J.R., Whitehead P.J., et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 83 (1991) 836-844
9. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Centers for Disease Control and Prevention; American Heart Association: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
10. Friedman G.D., Klatsky A.L., and Siegelaub A.B. The leukocyte count as a predictor of myocardial infarction. N. Engl. J. Med. 290 (1974) 1275-1278
11. Kannel W.B., Anderson K., and Wilson P.W. White blood cell count and cardiovascular disease: insights from the Framingham Study. JAMA 267 (1992) 1253-1256
12. Prentice R.L., Szatrowski T.P., Fujikura T., Kato H., Mason M.W., and Hamilton H.H. Leukocyte counts and coronary heart disease in a Japanese cohort. Am. J. Epidemiol. 116 (1982) 496-509
13. Olivares R., Ducimetiere P., and Claude J.R. Monocyte count: a risk factor for coronary heart disease?. Am. J. Epidemiol. 137 (1993) 49-53
14. Sweetnam P.M., Thomas H.F., Yarnell J.W., Baker I.A., and Elwood P.C. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am. J. Epidemiol. 145 (1997) 416-421
15. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497.
16. WHO. The Asia-Pacific perspective: refining obesity and its treatment. IOTF February 2000.
17. Tong P.C., Lee K.F., So W.Y., Ng M.H., Chan W.B., Lo M.K., et al. White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diab. Care 27 (2004) 216-222
18. Wang Y.Y., Lin S.Y., Liu P.H., Cheung B.M., and Lai W.A. Association between hematological parameters and metabolic syndrome components in a Chinese population. J. Diab. Complicat. 18 (2004) 322-327
19. Ford E.S. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173 (2004) 309-314
20. Vozarova B., Weyer C., Lindsay R.S., Pratley R.E., Bogardus C., and Tataranni P.A. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51 (2002) 455-461
21. Ohshita K., Yamane K., Hanafusa M., Mori H., Mito K., Okubo M., et al. Elevated white blood cell count in subjects with impaired glucose tolerance. Diab. Care 27 (2004) 491-496
22. Nieto F.J., Szklo M., Folsom A.R., Rock R., and Mercuri M. Leukocyte count correlates in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Epidemiol. 136 (1992) 525-537
23. Targher G., Seidell J.C., Tonoli M., Muggeo M., De Sandre G., and Cigolini M. The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J. Intern. Med. 239 (1996) 435-441
24. Fernandez-Real J.M., and Ricart W. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 42 (1999) 1367-1374
25. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 82 (1997) 4196-4200
26. Fernandez-Real J.M., Vayreda M., Richart C., Gutierrez C., Broch M., Vendrell J., et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J. Clin. Endocrinol. Metab. 86 (2001) 1154-1159
27. Sims E. Humoral Factors 1-373 (1993), IRL Press, Oxford
28. Festa A., D'Agostino Jr. R., Tracy R.P., and Haffner S.M. C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects: the Insulin Resistance Atherosclerosis Study. Diab. Med. 19 (2002) 939-943
29. Nappo F., Esposito K., Cioffi M., Giugliano G., Molinari A.M., Paolisso G., et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J. Am. Coll. Cardiol. 39 (2002) 1145-1150
30. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106 (2002) 2067-2072
31. Srinivasan S., Yeh M., Danziger E.C., Hatley M.E., Riggan A.E., Leitinger N., et al. Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circ. Res. 92 (2003) 371-377
32. Straczkowski M., Dzienis-Straczkowska S., Stepien A., Kowalska I., Szelachowska M., and Kinalska I. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J. Clin. Endocrinol. Metab. 87 (2002) 4602-4606
33. Hansen K., Sickelmann F., Pietrowsky R., Fehm H.L., and Born J. Systemic immune changes following meal intake in humans. Am. J. Physiol. 273 (1997) R548-R553
34. van Oostrom A.J., Sijmonsma T.P., Verseyden C., Jansen E.H., de Koning E.J., Rabelink T.J., et al. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J. Lipid. Res. 44 (2003) 576-583
35. Balkau B., Shipley M., Jarrett R.J., Pyorala K., Pyorala M., Forhan A., et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diab. Care 21 (1998) 360-367